|
Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial |
|
|
|
Titel: |
Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial |
Auteur: |
Li, Jun Xing, Jingliang Yang, Yefa Liu, Jingfeng Wang, Wentao Xia, Yong Yan, Zhenlin Wang, Kui Wu, Dong Wu, Lu Wan, Xuying Yang, Tian Gao, Chunfang Si, Anfeng Wang, Hongyang Wu, Mengchao Lau, Wan Yee Chen, Zhinan Shen, Feng |
Verschenen in: |
The Lancet gastroenterology & hepatology |
Paginering: |
Jaargang 5 () nr. 6 pagina's 548-560 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|